Global Glycomics Market Overview:
Global Glycomics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Glycomics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Glycomics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Glycomics Market:
The Glycomics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Glycomics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Glycomics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Glycomics market has been segmented into:
Enzymes [Glycosidases
Neuraminidases
Glycosyltransferases
Sialyltransferases
and Others]
Kits [Glycan Labeling Kits
Glycan Purification Kits
Glycan Release Kits
and Others]
Reagents [Glycoproteins
Monosaccharides
Oligosaccharides
and Others]
and Instruments [Mass Spectrometers
HPLC
MALDI-TOF
Array Systems
and Others]
By Application, Glycomics market has been segmented into:
Drug Discovery & Development
Diagnostics
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Glycomics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Glycomics market.
Top Key Players Covered in Glycomics market are:
Thermo Fisher Scientific
Inc.
Merck KgaA
Agilent Technologies Inc.
Bruker
New England Biolabs
Shimadzu Corporation
Waters Corporation
Takara Bio Inc.
Asparia Glycomics
RayBiotech Life
Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Glycomics Market Type
4.1 Glycomics Market Snapshot and Growth Engine
4.2 Glycomics Market Overview
4.3 Enzymes [Glycosidases
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Enzymes [Glycosidases: Geographic Segmentation Analysis
4.4 Neuraminidases
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Neuraminidases: Geographic Segmentation Analysis
4.5 Glycosyltransferases
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Glycosyltransferases: Geographic Segmentation Analysis
4.6 Sialyltransferases
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Sialyltransferases: Geographic Segmentation Analysis
4.7 and Others]
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 and Others]: Geographic Segmentation Analysis
4.8 Kits [Glycan Labeling Kits
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Kits [Glycan Labeling Kits: Geographic Segmentation Analysis
4.9 Glycan Purification Kits
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Glycan Purification Kits: Geographic Segmentation Analysis
4.10 Glycan Release Kits
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Glycan Release Kits: Geographic Segmentation Analysis
4.11 and Others]
4.11.1 Introduction and Market Overview
4.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.11.3 and Others]: Geographic Segmentation Analysis
4.12 Reagents [Glycoproteins
4.12.1 Introduction and Market Overview
4.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.12.3 Reagents [Glycoproteins: Geographic Segmentation Analysis
4.13 Monosaccharides
4.13.1 Introduction and Market Overview
4.13.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.13.3 Monosaccharides: Geographic Segmentation Analysis
4.14 Oligosaccharides
4.14.1 Introduction and Market Overview
4.14.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.14.3 Oligosaccharides: Geographic Segmentation Analysis
4.15 and Others]
4.15.1 Introduction and Market Overview
4.15.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.15.3 and Others]: Geographic Segmentation Analysis
4.16 and Instruments [Mass Spectrometers
4.16.1 Introduction and Market Overview
4.16.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.16.3 and Instruments [Mass Spectrometers: Geographic Segmentation Analysis
4.17 HPLC
4.17.1 Introduction and Market Overview
4.17.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.17.3 HPLC: Geographic Segmentation Analysis
4.18 MALDI-TOF
4.18.1 Introduction and Market Overview
4.18.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.18.3 MALDI-TOF: Geographic Segmentation Analysis
4.19 Array Systems
4.19.1 Introduction and Market Overview
4.19.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.19.3 Array Systems: Geographic Segmentation Analysis
4.20 and Others]
4.20.1 Introduction and Market Overview
4.20.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.20.3 and Others]: Geographic Segmentation Analysis
Chapter 5: Glycomics Market Application
5.1 Glycomics Market Snapshot and Growth Engine
5.2 Glycomics Market Overview
5.3 Drug Discovery & Development
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Drug Discovery & Development: Geographic Segmentation Analysis
5.4 Diagnostics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Diagnostics: Geographic Segmentation Analysis
5.5 and Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Glycomics Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.
6.4 MERCK KGAA
6.5 AGILENT TECHNOLOGIES INC.
6.6 BRUKER
6.7 NEW ENGLAND BIOLABS
6.8 SHIMADZU CORPORATION
6.9 WATERS CORPORATION
6.10 TAKARA BIO INC.
6.11 ASPARIA GLYCOMICS
6.12 RAYBIOTECH LIFE
6.13 INC.
Chapter 7: Global Glycomics Market By Region
7.1 Overview
7.2. North America Glycomics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Enzymes [Glycosidases
7.2.2.2 Neuraminidases
7.2.2.3 Glycosyltransferases
7.2.2.4 Sialyltransferases
7.2.2.5 and Others]
7.2.2.6 Kits [Glycan Labeling Kits
7.2.2.7 Glycan Purification Kits
7.2.2.8 Glycan Release Kits
7.2.2.9 and Others]
7.2.2.10 Reagents [Glycoproteins
7.2.2.11 Monosaccharides
7.2.2.12 Oligosaccharides
7.2.2.13 and Others]
7.2.2.14 and Instruments [Mass Spectrometers
7.2.2.15 HPLC
7.2.2.16 MALDI-TOF
7.2.2.17 Array Systems
7.2.2.18 and Others]
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Drug Discovery & Development
7.2.3.2 Diagnostics
7.2.3.3 and Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Glycomics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Enzymes [Glycosidases
7.3.2.2 Neuraminidases
7.3.2.3 Glycosyltransferases
7.3.2.4 Sialyltransferases
7.3.2.5 and Others]
7.3.2.6 Kits [Glycan Labeling Kits
7.3.2.7 Glycan Purification Kits
7.3.2.8 Glycan Release Kits
7.3.2.9 and Others]
7.3.2.10 Reagents [Glycoproteins
7.3.2.11 Monosaccharides
7.3.2.12 Oligosaccharides
7.3.2.13 and Others]
7.3.2.14 and Instruments [Mass Spectrometers
7.3.2.15 HPLC
7.3.2.16 MALDI-TOF
7.3.2.17 Array Systems
7.3.2.18 and Others]
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Drug Discovery & Development
7.3.3.2 Diagnostics
7.3.3.3 and Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Glycomics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Enzymes [Glycosidases
7.4.2.2 Neuraminidases
7.4.2.3 Glycosyltransferases
7.4.2.4 Sialyltransferases
7.4.2.5 and Others]
7.4.2.6 Kits [Glycan Labeling Kits
7.4.2.7 Glycan Purification Kits
7.4.2.8 Glycan Release Kits
7.4.2.9 and Others]
7.4.2.10 Reagents [Glycoproteins
7.4.2.11 Monosaccharides
7.4.2.12 Oligosaccharides
7.4.2.13 and Others]
7.4.2.14 and Instruments [Mass Spectrometers
7.4.2.15 HPLC
7.4.2.16 MALDI-TOF
7.4.2.17 Array Systems
7.4.2.18 and Others]
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Drug Discovery & Development
7.4.3.2 Diagnostics
7.4.3.3 and Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Glycomics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Enzymes [Glycosidases
7.5.2.2 Neuraminidases
7.5.2.3 Glycosyltransferases
7.5.2.4 Sialyltransferases
7.5.2.5 and Others]
7.5.2.6 Kits [Glycan Labeling Kits
7.5.2.7 Glycan Purification Kits
7.5.2.8 Glycan Release Kits
7.5.2.9 and Others]
7.5.2.10 Reagents [Glycoproteins
7.5.2.11 Monosaccharides
7.5.2.12 Oligosaccharides
7.5.2.13 and Others]
7.5.2.14 and Instruments [Mass Spectrometers
7.5.2.15 HPLC
7.5.2.16 MALDI-TOF
7.5.2.17 Array Systems
7.5.2.18 and Others]
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Drug Discovery & Development
7.5.3.2 Diagnostics
7.5.3.3 and Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Glycomics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Enzymes [Glycosidases
7.6.2.2 Neuraminidases
7.6.2.3 Glycosyltransferases
7.6.2.4 Sialyltransferases
7.6.2.5 and Others]
7.6.2.6 Kits [Glycan Labeling Kits
7.6.2.7 Glycan Purification Kits
7.6.2.8 Glycan Release Kits
7.6.2.9 and Others]
7.6.2.10 Reagents [Glycoproteins
7.6.2.11 Monosaccharides
7.6.2.12 Oligosaccharides
7.6.2.13 and Others]
7.6.2.14 and Instruments [Mass Spectrometers
7.6.2.15 HPLC
7.6.2.16 MALDI-TOF
7.6.2.17 Array Systems
7.6.2.18 and Others]
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Drug Discovery & Development
7.6.3.2 Diagnostics
7.6.3.3 and Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Glycomics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Enzymes [Glycosidases
7.7.2.2 Neuraminidases
7.7.2.3 Glycosyltransferases
7.7.2.4 Sialyltransferases
7.7.2.5 and Others]
7.7.2.6 Kits [Glycan Labeling Kits
7.7.2.7 Glycan Purification Kits
7.7.2.8 Glycan Release Kits
7.7.2.9 and Others]
7.7.2.10 Reagents [Glycoproteins
7.7.2.11 Monosaccharides
7.7.2.12 Oligosaccharides
7.7.2.13 and Others]
7.7.2.14 and Instruments [Mass Spectrometers
7.7.2.15 HPLC
7.7.2.16 MALDI-TOF
7.7.2.17 Array Systems
7.7.2.18 and Others]
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Drug Discovery & Development
7.7.3.2 Diagnostics
7.7.3.3 and Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Glycomics Scope:
|
Report Data
|
Glycomics Market
|
|
Glycomics Market Size in 2025
|
USD XX million
|
|
Glycomics CAGR 2025 - 2032
|
XX%
|
|
Glycomics Base Year
|
2024
|
|
Glycomics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Inc., Merck KgaA, Agilent Technologies Inc., Bruker, New England Biolabs, Shimadzu Corporation, Waters Corporation, Takara Bio Inc., Asparia Glycomics, RayBiotech Life, Inc..
|
|
Key Segments
|
By Type
Enzymes [Glycosidases
Neuraminidases
Glycosyltransferases
Sialyltransferases
and Others]
Kits [Glycan Labeling Kits
Glycan Purification Kits
Glycan Release Kits
and Others]
Reagents [Glycoproteins
Monosaccharides
Oligosaccharides
and Others]
and Instruments [Mass Spectrometers
HPLC
MALDI-TOF
Array Systems
and Others]
By Applications
Drug Discovery & Development
Diagnostics
and Others
|
